Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gender and regional equity in the European Society of Gynaecological Oncology: a longitudinal analysis of a professional medical society.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same author

Analysis of indocyanine green-guided sentinel lymph node mapping for cervical cancer during pregnancy.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same author

Challenges in Managing Undiagnosed Prenatal Sacrococcygeal Teratoma-Case Report and Literature Review.

Journal of clinical medicine·2026
Same author

Lenvatinib plus pembrolizumab in participants with advanced or recurrent endometrial cancer: Study 309/KEYNOTE-775 and ENGOT-en9/LEAP-001 post-(neo)adjuvant therapy outcomes.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same author

Benign metastasizing leiomyoma: a systematic review of diagnosis, management, and outcomes.

Chinese clinical oncology·2026
Same author

Pembrolizumab plus weekly paclitaxel in platinum-resistant recurrent ovarian cancer (ENGOT-ov65/KEYNOTE-B96): a multicentre, randomised, double-blind, phase 3 study.

Lancet (London, England)·2026

Related Experiment Video

Updated: Nov 24, 2025

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

12.3K

Sentinel lymph node in vulvar cancer.

Agnieszka Rychlik1, Mariusz Bidzinski1, Jakub Rzepka1

  • 1Department of Gynecologic Oncology, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland.

Chinese Clinical Oncology
|December 23, 2020
PubMed
Summary

Sentinel lymph node (SLN) biopsy is now standard for vulvar cancer, offering a less invasive alternative to full lymph node removal. This technique aids in detailed pathological examination and requires specialized centers for optimal outcomes.

Keywords:
Vulvar cancerindocyanine green (ICG)lymphoscintigraphyreviewsentinel lymph node (SLN)

More Related Videos

Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology
06:37

Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology

Published on: October 20, 2010

23.6K
The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
07:51

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

Published on: June 1, 2019

20.6K

Related Experiment Videos

Last Updated: Nov 24, 2025

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

12.3K
Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology
06:37

Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology

Published on: October 20, 2010

23.6K
The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
07:51

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

Published on: June 1, 2019

20.6K

Area of Science:

  • Oncology
  • Surgical Pathology
  • Gynecologic Oncology

Background:

  • Lymph node removal is standard for vulvar cancer.
  • Inguinal healing complications and patient morbidity necessitate alternative approaches.
  • Lymphatic mapping and sentinel lymph node (SLN) biopsy have gained prominence.

Purpose of the Study:

  • To review the literature on SLN techniques in vulvar cancer.
  • To discuss current recommendations and future research directions for SLN biopsy.
  • To highlight the benefits and challenges of SLN identification and pathological examination.

Main Methods:

  • Review of existing literature on SLN techniques and dyes for vulvar cancer.
  • Analysis of pathological ultra-staging methods for SLNs.
  • Evaluation of current international society recommendations for SLN use.

Main Results:

  • SLN biopsy is a minimally invasive alternative to full lymph node dissection for selected vulvar cancer patients.
  • Detailed pathological examination of fewer SLNs is possible.
  • The clinical significance of micrometastases found via ultra-staging requires further investigation.

Conclusions:

  • SLN biopsy is an established standard of care in vulvar cancer management.
  • The technique requires a learning curve and should be performed in expert centers.
  • Further research is needed to clarify the management of low-volume metastases identified by SLN ultra-staging.